More Entropy Neurodynamics Limited news
Entropy Neurodynamics LimitedASX: ENP

First Dosing in PLEXOVAL Exosome Wound Healing Human Study

Jan 28, 2020 at 1:32 AM EST · Issued by Entropy Neurodynamics Limited

Filed with ASX · Jan 28, 2020 at 1:32 AM EST

On 6ix: 6ix.com/news/first-dosing-in-plexoval-exosome-wound-healing-human-study

View Attachment

6ix hasn’t read this filing yet.

Entropy Neurodynamics Limited on 6ix

Earlier from Entropy Neurodynamics

  • Key Management Contracts ExtendedNov 25, 2019
  • Development Program UpdateNov 13, 2019
  • Appointment of Chief Commercial OfficerOct 27, 2019
  • Appendix 4C - quarterlyOct 24, 2019
  • Appendix 4E and Annual Financial Report FY 2019Aug 30, 2019

Later from Entropy Neurodynamics

  • December Quarterly Report and Appendix 4CJan 28, 2020
  • Independent Plexaris and Cevaris testingFeb 11, 2020
  • Cevaris testing shows positive results in models of EDFeb 18, 2020
  • Cevaris testing shows positive results in bladder controlFeb 19, 2020
  • Appendix 4D and Interim Financial ReportFeb 20, 2020
All Entropy Neurodynamics news releases↗

Follow Entropy Neurodynamics into a list and get an email when it puts out news.

Follow Entropy Neurodynamics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer